|
1
|
Cuervo AM: Chaperone-mediated autophagy:
Selectivity pays off. Trends Endocrinol Metab. 21:142–150. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Agarraberes FA, Terlecky SR and Dice JF:
An intralysosomal hsp70 is required for a selective pathway of
lysosomal protein degradation. J Cell Biol. 137:825–834. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park C, Suh Y and Cuervo AM: Regulated
degradation of Chk1 by chaperone-mediated autophagy in response to
DNA damage. Nat Commun. 6:68232015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saha T: LAMP2A overexpression in breast
tumors promotes cancer cell survival via chaperone-mediated
autophagy. Autophagy. 8:1643–1656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kon M, Kiffin R, Koga H, Chapochnick J,
Macian F, Varticovski L and Cuervo AM: Chaperone-mediated autophagy
is required for tumor growth. Sci Transl Med. 3:109ra1172011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou J, Yang J, Fan X, Hu S, Zhou F, Dong
J, Zhang S, Shang Y, Jiang X, Guo H, et al: Chaperone-mediated
autophagy regulates proliferation by targeting RND3 in gastric
cancer. Autophagy. 12:515–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Altenberg B and Greulich KO: Genes of
glycolysis are ubiquitously overexpressed in 24 cancer classes.
Genomics. 84:1014–1020. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Majumder PK, Febbo PG, Bikoff R, Berger R,
Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR,
et al: mTOR inhibition reverses Akt-dependent prostate
intraepithelial neoplasia through regulation of apoptotic and
HIF-1-dependent pathways. Nat Med. 10:594–601. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mazurek S, Boschek CB, Hugo F and
Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth
and spreading. Semin Cancer Biol. 15:300–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dombrauckas JD, Santarsiero BD and Mesecar
AD: Structural basis for tumor pyruvate kinase M2 allosteric
regulation and catalysis. Biochemistry. 44:9417–9429. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li YH, Li XF, Liu JT, Wang H, Fan LL, Li J
and Sun GP: PKM2, a potential target for regulating cancer. Gene.
668:48–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H,
Zha Z, Liu Y, Li Z, Xu Y, et al: Acetylation targets the M2 isoform
of pyruvate kinase for degradation through chaperone-mediated
autophagy and promotes tumor growth. Mol Cell. 42:719–730. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang S, Hu B, You Y, Yang Z, Liu L, Tang
H, Bao W, Guan Y and Shen X: Sorting nexin 10 acts as a tumor
suppressor in tumorigenesis and progression of colorectal cancer
through regulating chaperone mediated autophagy degradation of
p21Cip1/WAF1. Cancer Lett. 419:116–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arias E and Cuervo AM: Pros and cons of
chaperone-mediated autophagy in cancer biology. Trends Endocrinol
Metab. 31:53–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Feng G, Bao G, Xu G, Sun Y, Li W,
Wang L, Chen J, Jin H and Cui Z: Nuclear translocation of PKM2
modulates astrocyte proliferation via p27 and -catenin pathway
after spinal cord injury. Cell Cycle. 14:2609–2618. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Azoitei N, Becher A, Steinestel K, Rouhi
A, Diepold K, Genze F, Simmet T and Seufferlein T: PKM2 promotes
tumor angiogenesis by regulating HIF-1α through NF-κB activation.
Mol Cancer. 15:32016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Wit RH, Mujić-Delić A, van Senten JR,
Fraile-Ramos A, Siderius M and Smit MJ: Human cytomegalovirus
encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in
glioblastoma cells. Oncotarget. 7:67966–67985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng JQ, Han SM, Chen ZH, Yang J, Pei YQ,
Bao C, Qiao L, Chen WQ and Liu B: Chaperone-mediated autophagy
regulates apoptosis and the proliferation of colon carcinoma cells.
Biochem Biophys Res Commun. 522:348–354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang J, Cao R, Wang X, Zhang Y, Wang P,
Gao H, Li C, Yang F, Zeng R, Wei P, et al: Mitochondrial PKM2
regulates oxidative stress-induced apoptosis by stabilizing Bcl2.
Cell Res. 27:329–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu WQ, Hu YY, Lin XP and Fan W: Knockdown
of PKM2 and GLS1 expression can significantly reverse
oxaliplatin-resistance in colorectal cancer cells. Oncotarget.
8:44171–44185. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan S, Qiao T, Zhuang X, Chen W, Xing N
and Zhang Q: Knockdown of the M2 isoform of pyruvate kinase (PKM2)
with shRNA enhances the effect of docetaxel in human NSCLC cell
lines in vitro. Yonsei Med J. 57:1312–1323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gorantla NV and Chinnathambi S: Autophagic
pathways to clear the tau aggregates in Alzheimer's disease. Cell
Mol Neurobiol. 41:1175–1181. 2021. View Article : Google Scholar : PubMed/NCBI
|
